Bergenin Plays an Anti-Inflammatory Role Via the Modulation of MAPK and NF-κB Signaling Pathways in a Mouse Model of LPS-Induced Mastitis
Overview
Pathology
Affiliations
Mastitis is a major disease in humans and other animals and is characterized by mammary gland inflammation. It is a major disease of the dairy industry. Bergenin is an active constituent of the plants of genus Bergenia. Research indicates that bergenin has multiple biological activities, including anti-inflammatory and immunomodulatory properties. The objective of this study was to evaluate the protective effects and mechanism of bergenin on the mammary glands during lipopolysaccharide (LPS)-induced mastitis. In this study, mice were treated with LPS to induce mammary gland mastitis as a model for the disease. Bergenin treatment was initiated after LPS stimulation for 24 h. The results indicated that bergenin attenuated inflammatory cell infiltration and decreased the concentration of NO, TNF-α, IL-1β, and IL-6, which were increased in LPS-induced mouse mastitis. Furthermore, bergenin downregulated the phosphorylation of nuclear factor-kappaB (NF-κB) and mitogen-activated protein kinases (MAPK) signaling pathway proteins in mammary glands with mastitis. In conclusion, bergenin reduced the expression of NO, TNF-α, IL-1β, and IL-6 proinflammatory cytokines by inhibiting the activation of the NF-κB and MAPKs signaling pathways, and it may represent a novel treatment strategy for mastitis.
Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis.
Khan M, Li L, Zhan Y, Binjiang H, Liu X, Kou X Front Immunol. 2025; 16:1425901.
PMID: 39991157 PMC: 11842335. DOI: 10.3389/fimmu.2025.1425901.
Abera B, Abdissa N, Endale M, Melaku Y, Shenkute K, Ensermu U Biochem Res Int. 2024; 2024:1322756.
PMID: 39659700 PMC: 11631344. DOI: 10.1155/bri/1322756.
Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders.
Rezaiezadeh H, Langarizadeh M, Tavakoli M, Sabokro M, Banazadeh M, Kohlmeier K Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8349-8366.
PMID: 38850305 DOI: 10.1007/s00210-024-03197-2.
Phan U, Nguyen H, Nguyen T, Tran T, Le T, Tran T Heliyon. 2024; 10(4):e26174.
PMID: 38404825 PMC: 10884859. DOI: 10.1016/j.heliyon.2024.e26174.
Ski ameliorates synovial cell inflammation in monosodium iodoacetate-induced knee osteoarthritis.
Xiong A, Xiong R, Luo F Heliyon. 2024; 10(2):e24471.
PMID: 38298665 PMC: 10827772. DOI: 10.1016/j.heliyon.2024.e24471.